CDC: 2012-2013 flu vaccine not as effective in elderly

CDC: 2012-2013 flu vaccine not as effective in elderly
Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

(HealthDay)—Vaccination against influenza for the 2012/2013 flu season appears to be moderately effective in reducing the need for outpatient medical attention, but the effect is lower in the elderly, according to research published in the Feb. 22 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Lisa Jackson, M.D., of the CDC in Atlanta, and colleagues analyzed data from the U.S. Influenza Vaccine Effectiveness Network to estimate vaccine effectiveness (VE) for the 2012/2013 influenza season.

The researchers estimated the overall VE against influenza A and B to be 47 and 67 percent, respectively, or 56 percent overall, which was close to the interim estimate of 62 percent. When stratified by age group, the estimates for VE against influenza A (H3N2) and B infections were mostly consistent across age groups, with the exception that lower VE against influenza A (H3N2) was seen among adults aged 65 and older. These findings suggest vaccination against influenza reduces the risk of illness requiring outpatient medical visits by one-half to two-thirds for most people, although VE was lower and not statistically significant among people aged 65 and older.

"Antiviral medications should be used as recommended for treatment of suspected influenza in certain patients, including those aged ≥65 years, regardless of their influenza vaccination status," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

CDC: Influenza activity increasing across the U.S.

Jan 05, 2013

(HealthDay)—Flu season descended on the United States early and hard this winter, with significant increases in flu activity observed over the past month, according to an update issued Jan. 4 by the U.S. ...

Recommended for you

FDA approves new, hard-to-abuse hydrocodone pill

3 hours ago

Federal health regulators have approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards.

Soaring generic drug prices draw Senate scrutiny

7 hours ago

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

17 hours ago

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

Interpol call for roadmap to tackle fake drugs

Nov 19, 2014

Interpol on Wednesday called for a greater global response to pharmaceutical crime as it warned criminal gangs were capitalising on weaknesses in legislation and border controls.

Empagliflozin in type 2 diabetes: Added benefit not proven

Nov 19, 2014

Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. The German Institute for Quality and ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.